These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7599161)

  • 1. D-myo-inositol 1,4,5-trisphosphate analogues substituted at the 3-hydroxyl group.
    Hirata M; Watanabe Y; Kanematsu T; Ozaki S; Koga T
    Biochim Biophys Acta; 1995 Jun; 1244(2-3):404-10. PubMed ID: 7599161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes.
    Hirata M; Watanabe Y; Yoshida M; Koga T; Ozaki S
    J Biol Chem; 1993 Sep; 268(26):19260-6. PubMed ID: 8396130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of phosphorofluoridate analogues of D-myo-inositol 1,4,5-trisphosphate to assess the involvement of ionic interactions in its recognition by the receptor and metabolising enzymes.
    Yoshimura K; Watanabe Y; Erneux C; Hirata M
    Cell Signal; 1999 Feb; 11(2):117-25. PubMed ID: 10048789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
    FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of inositol 1,4,5-trisphosphate analogues by 3-kinase and dephosphorylation of inositol 1,3,4,5-tetrakisphosphate analogues by 5-phosphatase.
    Van Dijken P; Lammers AA; Ozaki S; Potter BV; Erneux C; Van Haastert PJ
    Eur J Biochem; 1994 Dec; 226(2):561-6. PubMed ID: 8001571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV
    Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
    Hirata M; Narumoto N; Watanabe Y; Kanematsu T; Koga T; Ozaki S
    Mol Pharmacol; 1994 Feb; 45(2):271-6. PubMed ID: 8114676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR
    J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Riley AM; Lindley CJ; Jenkins DJ; Westwick J; Potter BV
    Mol Pharmacol; 1997 Oct; 52(4):741-8. PubMed ID: 9380038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase.
    Safrany ST; Sawyer D; Wojcikiewicz RJ; Nahorski SR; Potter BV
    FEBS Lett; 1990 Dec; 276(1-2):91-4. PubMed ID: 2176165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
    Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV
    Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition.
    Safrany ST; Wilcox RA; Liu C; Potter BV; Nahorski SR
    Eur J Pharmacol; 1992 Jul; 226(3):265-72. PubMed ID: 1330634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor.
    Safrany ST; Sawyer DA; Nahorski SR; Potter BV
    Chirality; 1992; 4(7):415-22. PubMed ID: 1334423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-myo-inositol 1,4,5-trisphosphate analogues modified at the 3-position inhibit phosphatidylinositol 3-kinase.
    Ward SG; Mills SJ; Liu C; Westwick J; Potter BV
    J Biol Chem; 1995 May; 270(20):12075-84. PubMed ID: 7744856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; McBain J; Cooke AM; Potter BV; Nahorski SR
    Mol Pharmacol; 1991 Jun; 39(6):754-61. PubMed ID: 1646949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
    FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and application of photoaffinity analogues of inositol 1,4,5-trisphosphate selectively substituted at the 1-phosphate group.
    Schäfer R; Nehls-Sahabandu M; Grabowsky B; Dehlinger-Kremer M; Schulz I; Mayr GW
    Biochem J; 1990 Dec; 272(3):817-25. PubMed ID: 2176480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel Ins(1,4,5)P3 analogue 3-amino-3-deoxy-Ins(1,4,5)P3: a pH-dependent Ins(1,4,5)P3 receptor partial agonist in SH-SY5Y neuroblastoma cells.
    Kozikowski AP; Fauq AH; Wilcox RA; Challiss RA; Nahorski SR
    J Med Chem; 1994 Mar; 37(6):868-72. PubMed ID: 8145238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.